James Trager
- Aging top 2%
- Physiology top 2%
- Telomeres, Telomerase, and Senescence 3
- Immunology top 5%
- Immune Cell Function and Interaction 16
- Immunotherapy and Immune Responses 12
- Oncology top 5%
- CAR-T cell therapy research 26
- Cancer Immunotherapy and Biomarkers 14
- Biotechnology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Cancer Genomics and Diagnostics 3
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Gregg B. MorinWoodring E. WrightShawn E. HoltNadeem A. SheikhSerge LichtsteinerAndrea BodnárWilliam H. AndrewsR. Pruzan
- Cited by
- AgingPhysiologyImmunology
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
James Trager
48 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Aging 109
- Physiology 980
- Immunology 640
- Oncology 622
- Biotechnology 178
Countries citing papers authored by James Trager
This map shows the geographic impact of James Trager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Trager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Trager more than expected).
Fields of papers citing papers by James Trager
This network shows the impact of papers produced by James Trager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Trager. The network helps show where James Trager may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Trager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 1 | |
| 8 | 2017 | 22 | |
| 9 | 2016 | 50 | |
| 10 | 2016 | 156 | |
| 11 | 2015 | 101 | |
| 12 | 2013 | 14 | |
| 13 | 2012 | 203 | |
| 14 | 2012 | 24 | |
| 15 | 2012 | 9 | |
| 16 | 2002 | 4 | |
| 17 | 1999 | 442 | |
| 18 | 1997 | 6 | |
| 19 | Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRTbreakdown → | 1997 | 812 |
| 20 | 1994 | 29 |
About James Trager
James Trager is a scholar working on Immunology, Oncology and Aging, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (26 papers), Immune Cell Function and Interaction (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (12 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Telomeres, Telomerase, and Senescence (3 papers), Cancer Genomics and Diagnostics (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Aging (109 citations), Physiology (980 citations) and Immunology (640 citations). James Trager has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Gregg B. Morin, Woodring E. Wright, Shawn E. Holt, Nadeem A. Sheikh, Serge Lichtsteiner, Andrea Bodnár, William H. Andrews, R. Pruzan, Scott L. Weinrich and Libin Ma. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Blood, Clinical Cancer Research and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.